Pediatrics in Review
HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Pediatrics in Review. 2000;21:291-295. doi:10.1542/10.1542/pir.21-9-291)
© 2000 American Academy of Pediatrics

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Take the CME quiz:
Vol. 21 No. 9, September 2000
Right arrow Rapid Responses: Submit a response
Right arrow Rapid Responses: View responses
Right arrow Alert me when this article is cited
Right arrow Alert me when Rapid Responses are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hyams, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hyams, J. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Inflammatory Bowel Disease


Jeffrey S. Hyams, MD*

* Head, Division of Digestive Diseases and Nutrition, Connecticut Children’s Medical Center; Professor of Pediatrics, University of Connecticut School of Medicine, Hartford, CT. Dr Hyams is a Consultant, National Treatment Registry for Remicade for Centocor, Inc.


    OBJECTIVES
 
After completing this article, readers should be able to:

  1. Describe the primary clinical difference between Crohn disease and ulcerative colitis.
  2. List the greatest single risk factor for developing inflammatory bowel disease.
  3. Delineate the primary presentation of children and adolescents who have Crohn disease.
  4. Explain the effects of prolonged daily use of high-dose corticosteroids.
  5. Describe the primary risk factor for intestinal cancer associated with both ulcerative colitis and Crohn disease.


    Introduction
 
Inflammatory bowel disease (IBD) is a generic term used to describe two idiopathic disorders that are associated with gastrointestinal inflammation: Crohn disease (CD) and ulcerative colitis (UC). These disorders need to be distinguished from other conditions that may display similar clinical and laboratory findings, such as infection, allergy, and neoplasm. Because IBD also may be associated with a large array of extraintestinal manifestations, a knowledge of the clinical spectrum of these disorders is important to the clinician who may encounter associated pediatric problems such as growth delay, arthritis, hepatitis, and anemia. Once IBD is diagnosed, newer medical and surgical treatment modalities allow most affected children to lead relatively normal lives.


    Definitions
 
The ultimate definition of UC and CD rests with the location and characteristics of inflammation within the gastrointestinal tract. In UC, a relatively homogeneous inflammatory process is confined to the mucosa, which starts in the rectum and involves a variable extent of colon proximally. Crypt abscesses are common. Contrary to historical belief, patients may have discontinuous inflammation at diagnosis or even rectal sparing, but over the course of the illness the inflammation becomes more confluent. Inflammation limited to the rectum, observed in 10% of patients, is termed ulcerative proctitis. In about 30% of cases, the disease is limited to the left side of the colon; in 40% to 50%, there is pancolitis.

The inflammation associated with CD may involve any portion . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
GutHome page
A Laghi, O Borrelli, P Paolantonio, L Dito, M B. de Mesquita, P Falconieri, R Passariello, and S Cucchiara
Contrast enhanced magnetic resonance imaging of the terminal ileum in children with Crohn's disease
Gut, March 1, 2003; 52(3): 393 - 397.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
K. Kunzelmann and M. Mall
Electrolyte Transport in the Mammalian Colon: Mechanisms and Implications for Disease
Physiol Rev, January 1, 2002; 82(1): 245 - 289.
[Abstract] [Full Text] [PDF]

Rapid Responses:

Read all Rapid Responses

adenocarcinoma
Abelman
Pediatrics in Review Online, 31 May 2001 [Full text]
Re: adenocarcinoma
Jeffrey Hyams
Pediatrics in Review Online, 31 May 2001 [Full text]



HOME HELP CONTACT US SUBSCRIPTIONS CME ARCHIVE SEARCH TABLE OF CONTENTS
Pediatrics  Pediatrics in Review
Copyright © 2000 by the American Academy of Pediatrics.